Aim: The aim of the present work was to focus on the applicability of liposomes and ethosomes for transdermal delivery. In the current review, we had focused on transdermal delivery transdermal delivery of vesicular system vesicular systems, i.e., liposome and ethosomes, factors affecting their permeation and penetration efficiency, limitations, applications, method of preparations, evaluation parameters, and selection of lipids. In this review, we considered the mechanism of controlled drug release of vesicles by transdermal delivery and the impact of their physicochemical properties. Rheumatoid arthritis (RA) is most frequently suffering disease in the geriatric population. By transdermal delivery, conventional anti-RA (ARA) therapy associated with several disadvantages. The modern ARA therapy; disease-modifying antirheumatic drugs (DMARDs) are more effective in reducing down disease progression. The basic mechanism of action of DMARDs in RA is not clear. The vesicles have a potential role in RA; especially, we focused on the impact of liposomes and ethosomes on RA by transdermal delivery, vesicular mechanism to justification in ARA therapy. Conclusion: The liposomes and ethosomes were beneficial tools for transdermal delivery. They have a potential role to control RA by transdermal delivery.
INTRODUCTION
T he skin is the multilayered largest portion of an average adult body. It covers around 2 m 2 of surface area and receives approximately one-third of all blood circulating through the body. It controls influx of toxins, efflux of water and shows impermeable nature to the foreign molecules. The skin acts as a potential barrier due to stratum corneum, which represents the outer layer of the epidermis. Which imparts the barrier properties to the skin and inhibit the penetration of the active substances across the skin. [1] The human skin consists of three main layers: epidermis, dermis and hypodermis. the stratum corneum is the first layer of the skin, plays the rate limiting barrier to various substances to permeate or penetrate through the skin. The human body contains 60% of water, whereas stratum corneum contains only 20% of water. It has 10-15 μm thickness and density 1.4 g/cm 3 depending on its state of hydration. The stratum corneum contains dried dead corneocytes, enriched keratin fibers with 0.2-0.4 μm thickness and 40 μm wide. The corneodesmosomes maintain structure stability by corneocytes is held together which confer structural stability to the stratum corneum. The lipids in the stratum corneum prevent excessive loss of water from the body. Every month, these corneocytes are usually regenerated. The epidermis is a multilayered membrane, and it contains 75-150 μm thickness. This layer does not contain blood vessels. The epidermis is hydrophilic in nature. The dermis contains thickness around 3-5 μm. The dermis layers full of with nerves, capillaries, sweat glands, sebaceous glands, and hair follicles. These are all frame into a network of connective tissue. [1, 2] The considerable advantages over the established and easier oral route are: [1] [2] [3] [4] [5] Good patient compliance because of its little risk and simple way of administration. This mode thwarts the fluctuations which appear at gastrointestinal absorption.
• Self-medication is possible, removal of the dosage form at the will of the patient • Controlled drug administration by controlling the drug plasma distribution and decrease the dosing frequency • It outflanks hepatic metabolism and increases systemic absorption and bioavailbility • Decreases dosing frequency, dose, and the cost • Reduced toxic manifestations.
Factors affecting permeation across the skin [6] [7] [8] Diffusion process controlled the transportation of active substances across the skin. The permeation of various active substances such hydrophilic and lipophilic is governed by Fick's first law. Several factors affect the permeation profiles of active substance through the skin such as solubility, charge, partition coefficient (Log P), molecular weight (molecular weight not exceeding 500 Daltons), and concentration gradient. The permeation efficiency is dependent on solubility and the partition coefficient of the drug. The partition coefficient (Log P) more than 2 is difficult to diffuse and does not partition into stratum corneum. At physiological temperature, stratum corneum (formidable barrier) maintains brick and mortar nature. Limited number of hydrophobic molecules able to cross the skin during this condition. Lipophilic molecules easily permeate across stratum corneum in presence of the delivery system by altering the order of stratum corneum, whereas hydrophilic molecules required some external energy to permeate across the stratum corneum. The aqueous solubility should be maintaining more than 1 mg/mL. pH-partition hypothesis states that molecules mainly cross biological membranes in unionized form. [9] Molecular weight is also one of the factors to choose the active substance. Molecules for transdermal drug delivery should have low molecular weight typically <500 Daltons. The lipophilicity should be in the range of 1-3. When we are selecting an active substance for transdermal delivery, the dose is also important parameter. Active substance should have a low dose and high potency. [10] Transportation of active substances to the systemic ciculation through the skin is seen as a desirable alternative to oral medication. Transdermal drug delivery has advantage to bypass the gastrointestinal tract (GIT) which would obviate the GIT irritation that frequently occurs and avoid partial first pass metabolism by the liver. For many years, there was a speculation that active transport mechanisms occurring within skin were responsible for its unique barrier properties.
Transport of drugs through the skin
The work of Scheuplein ultimately clarified the origin of skin permeability to molecular substances and established it as a passive diffusive process rather than a biologically active property. Through extensive studies, it was conclusively proven that the principle barrier to permeation is stratum corneum and that it is at least three to five times less permeable than the dermis and that permeability of the entire epidermis was indistinguishable from that of the stratum corneum alone. Skin permeation occurs by Fickian diffusion of the penetrating species, with the gradient impenetrate concentration across the entire skin localizes within the stratum corneum.
Routes of drug penetration through the skin [10] [11] [12] Two pathways through the intact barrier may be identified, the intercellular and transcellular route. The intercellular lipid route is between the corneocytes, whereas transcellular route contemplates the crossing through the corneocytes and the intervening lipids. The permeation of drugs through skin includes diffusion through the intact epidermis through skin appendages. The skin appendages are hair follicles, sweat glands, and sebaceous glands form shunt pathways through the intact epidermis, occupying only 0.1% of the total human skin. It is known drug permeation through the skin is usually limited by the stratum corneum.
Recently, follicular penetration has become a major focus of interest due to the drug targeting to the hair follicle is of great interest in the treatment of skin diseases. However, follicular orifices occupy only 0.1% of the total skin surface area; it was assumed as a non-important route. However, a variety of studies shown the hair follicles could be a way to trough the skin. Skin being the largest organ of the human body and part of its physical and physiological functions; it is a vital and promising route of drug transport because of its abundance, large surface area, simple and highly preferred route because of the ideal advantages. This can be assuring via the research done on the transdermal route in the last few decades and increased market expected to reach $32 billion in 2015. [13] Time has brought enough changes and drug delivering strategies to improve patient compliance and decrease toxic manifestations. Development in novel technologies associated with specific requirements majorly to accomplish patient suitability, targeted and appropriate usage of drug, illustrated and proven methodologies to overcome the drug-related drawbacks and formulation associated difficulties, physiological requirements had entertained the innovators to produce positive ways of new methodologies and logical determination of every tiny aspect opened the doors for supplementary portal to deliver drug in a safe and satisfactory way technically, ethically, and economically. The transdermal route of drug delivery has many advantages for administration of drugs in local and systemic therapy, but the skin is widely recognized for its effective barrier properties compared with other biological membranes.
The low permeability of the skin makes it a minor port of entry for drugs. During the past decades, there has been wide interest in exploring new techniques such as physical permeation enhancement technique (iontophoresis, [14, 15] electroporation, [16] sonophoresis, [17] microneedles, [18, 19] jet injectors, suction ablation, and thermophoresis) and passive penetration enhancement technique (saturated solutions [20] and penetration enhancers [21, 22] ) to increase drug absorption through skin. Transdermal drug delivery of drugs by lipid vesicles has evoked a considerable interest. [23, 24] In the current review, we have been focused on liposomes and ethosomes for transdermal delivery. [25, 26] In general, dispersion systems are defined as systems where one immiscible phase is dispersed in another continuous phase. According to Banker Modern Pharmaceutics, [27] the dispersion systems are classified into three categories such as molecular level, colloidal level, and coarse level as mentioned in Table 1 . The molecular dispersions are not visible by advanced electronic microscopes such as transmission electron microscopy (TEM). The coarse dispersion systems such as emulsions and suspensions could be visible by a compound microscope. The colloidal dispersions (liposomes, ethosomes, and nanoparticles) could be visible with scanning electron microscope (SEM) and TEM. The colloidal dispersions governed various carrierbased drug delivery systems such as niosomes, liposomes, ethosomes, nanoparticles, and mixed micelles [ Table 1 ]. [28] Colloidal dispersions have a potential role on skin drug delivery. They have ability to overcome barrier properties of the skin without affecting skin structure and more potential than conventional dosage forms such as creams, ointments, and lotions. [28] In the current review, we had focused on the applicability and limitations, preparation, evaluation parameters, selection of lipids for liposomal and ethosomal vesicular dispersions for transdermal delivery and their role in rheumatoid arthritis (RA).
Liposomes
Liposomes were first described by Bangham et al., in 1965. Liposomes are microparticulate or colloidal carriers. Which are usually 0.05-5.0 μm in diameter and form spontaneously when certain lipids are hydrated in aqueous medium. Liposomes are microscopic spherical shaped vesicles composed of a bilayer of phospholipids with or without cholesterol. They can encapsulate and effectively deliver both hydrophilic and hydrophobic substances. [29] [30] [31] Attractive biological properties of liposomes: [23] [24] [25] [26] [27] [28] [29] [30] [31] • Liposomes are biocompatible, biodegradable, and nontoxic phospholipid-based systems 
Liposomes as carrier for dermal drug delivery systems
Huge research was done on liposomes as drug delivery systems for dermal delivery. However, there was no clarity on its mechanism to transport active molecules across the skin. Different approaches were proposed for the mechanism of liposomes for dermal delivery. [30] [31] [32] [33] Few are as following: In general, stratum corneum is lipophilic in nature. It contains corneocytes, enriched keratin fibers (contain 50% phosphatidylcholine). These corneocytes are providing a fluidity (aqueous) environment for the diffusion of drug substances. When applying liposomes for dermal delivery, liposomes were interact with hydrophilic portion of the lipids in stratum corneum. At this condition, the phase transition temperature of the skin was decreased by increasing the fluidity in the skin helps the vesicles, could be easily alter the structure of the skin and easily squeezes into the skin and release drugs. It indicated that state of skin hydration played one of the key factors in the diffusion process through the skin. The permeation profile of drug substance strongly depends on the state of skin hydration. Human body contains water content around 10-20%. The occlusive conditions are more favorable to control the water content in the skin. In general, liposomes have occlusive properties to increase the skin humidity and consequently maintain the barrier functions of the skin. When treating liposomes for topical delivery, liposomes use to adsorb on the skin and maintain lipid concentration on the stratum corneum. The skin hydration is completely depends on phospholipid concentration on the skin. When we are developing liposomes for dermal delivery, natural lipids are more preferable compared to synthetic lipids. Natural lipids are maintained the barrier function and having ability to alter the permeation profile and decrease the side effects of the drug substance. The composition and properties of liposomes are the key factors in their permeation into the skin.
Basically, liposomes are colloidal suspensions. In this state, liposomal vesicles are in random in motion (thermal motion). At liquid state, liposomes are showing better results as skin drug delivery. However, the ultimate dosage form of skin delivery is semisolids such as ointments and gels. In general, semisolid dosage forms are usually maintained the higher skin contact time. As suspension for dermal delivery, it shows less skin contact time because they could easily evaporate. Nowa-day, gels more passionable dosage form to load liposomes compared to ointments and lotions. When loading liposomes into the polymeric gel barrier, vesicles movement completely restricted. The vesicles movement in the gels completely depends on viscosity profiles of gels. Hence, the pseudoplastic nature of viscosity is more favorable for gel preparation.
Recently, many research groups are using differential scanning calorimetry (DSC) [34] and spectroscopy (infrared [IR]) [35] to predict the permeation profiles of liposomal vesicles through skin. DSC studies can be useful to predict the skin fluidity by exerting phase transition temperature of the skin and by Fourier transform IR studies, elucidation of lipid functional groups in the skin. When liposomes are applied on the skin, they could interact with a lipid portion of the stratum corneum; it leads to alter functional groups slightly from the normal skin stage to treated skin stage.
Liposomes can exert different functions by topical application. They could improve drug deposition (by adsorb on the skin) within the skin at the site of action (i.e. provides a localizing effect). The liposomal adsorption on the skin may promote a lipid exchange between phospholipid of bilayer and cellular skin lipids. The drug permeation and penetration profiles of liposomes were affected by several factors such as lipid compositions, vesicles size, and physicochemical properties of active molecules, vesicle membrane bilayer structure, and preparation methods.
Many researchers have given a statement about the role of liposomes for systemic delivery. They said that liposomes are basically rigid in nature, and they could easily adsorb on the skin and promote local action. Due to their rigid nature, liposomes were failed to enhance the systemic delivery (not enable to cross stratum corneum). The rigid liposomes decreased the bilayer membrane fluidity, and thus decrease the penetration rate of vesicles through the skin. The stratum corneum plays rate-limiting role in the modulation of systemic absorption of active substances through the skin. Vast research done on the conventional liposomal formulations for a transdermal application made them to think about the new developments but did not show fruitful results as they cannot pass the stratum corneum effectively. [29] [30] [31] [32] Here, we are giving some reference to support above statements. Fadda et al. [36] developed phycocyanin loaded liposomes by the film hydration techniques. They reported that phycocyanin (C-Pc) loaded liposomes were adsorbed on stratum corneum and accumulated C-Pc on stratum corneum. They reported that liposomes do not have ability to permeate the C-Pc into deep skin layers. In this study, liposomes were showed below 50% of encapsulation efficiency.
Recently Sudhakar et al. [37] developed terbinafine loaded liposomes by ethanol injection method using phospholipon 90H and DMPC. In this study, the encapsulation efficiency of liposomes showed 70%, and the in vitro permeation showed 72.62 ± 0.22% per 12 h. They reported that liposomal in vitro behavior completely affected the concentration of cholesterol. The above two references strongly indicated that liposomes were failure to increase the encapsulation efficiency above 90%. In vitro release studies indicated that liposomes failure to produce the systemic delivery. In general, formulation efficiency is dependent on physicochemical properties of the active substance, formulation properties, and biological barriers (skin). The low encapsulation, as well as low permeation profiles, leads to insufficient bioavailability of active substances from liposomal formulations through the skin.
To overcome this cusp (liposomal vesicular systems could not cross the stratum corneum), a new way which acted as viaduct to cross the stratum corneum and to deliver the drug considerably, a new liposomes-enriched (45% of ethanol) model has been developed and introduced a novel generation of vesicular elastic systems.
Ethosomes
Ethosomes was developed by Touitou. They are deformable liposomes embedded high alcohol content (up to 45%). Ethosomes are composed of phospholipid, ethanol, and water and with or without cholesterol. Liposomes and ethosomes are not alternative to each other. Ethosomes are quite different from liposomes on morphology, physicochemical properties, and mechanism of action. In general, ethosomes use to maintain 45% of ethanol, due to this reason; ethosomes are differentiated from other vesicular systems. The particle sizes of ethosomes are available from 30 to 200 nm due to 45% of ethanol. The higher concentration of ethanol causes the vesicle bilayer self-degradation of interpenetrating character, leads to form lower particle size than conventional liposomes. It is proposed that alcohol fluidizes the lipid bilayer and stratum corneum bilayer lipids, thus acquiesces the soft, tractable ethosomes to penetrate through the stratum corneum. Naturally, ethosomes are soft, malleable sub-micron size spherical shaped vesicles. Ethosomes are permeated significantly through the skin layers more rapidly and enhanced steady state concentration (higher flux) in comparison to conventional liposomes. Although, the exact mechanism for better permeation into deeper skin layers from ethosomes is still not clear. The combined effect of phospholipid and high concentration of ethanol in vesicular formulations has been suggested to be responsible for deeper distribution and penetration in the skin lipid bilayers, but the highest ethanolic concentration is the devastating negative thing associated with ethosomes. [29, 38] Advantages of ethosomes [29, [37] [38] [39] [40] [41] • Ethosomes are versatile carrier-based drug delivery systems and could be encapsulate hydrophilic, lipophilic, and amphiphilic molecule • By transdermal route, ethosomes can deliver drugs in a passive manner • During development of ethosomes, phospholipids vesicles can exist higher ethanol concentration (up to 45%) • Ethosomal vesicles are soft, malleable in nature due to the presence of ethanol in the vesicles; it has a fluidizing effect on lipid bilayer vesicles • Ethosomes can alter the solubility properties of active ingredients in the vesicles leads to increase the permeation profile • Ethosomal vesicles bilayer packed very less tightly, possess a high degree of fluidity and has lower transition temperature compared to liposomes • Ethosomal vesicles maintain synergistic effect between ethanol, phospholipid vesicles, and skin, thus enhances drug transport compared to conventional liposomal rigid vesicles • Ethosomes showing better stability compared to liposomes due to the negative charge of the net system avoiding aggregation of vesicles during their stability.
Touitou et al. [41] studied testosterone loaded ethosomes by cold preparation method. They were studied in vitro permeation studies on human cadaver skin. They reported the in vitro permeation was more for ethosomes (594.57 ± 39.9 μg) compared to marketed formulation (Androgel ® ) (92.27 ± 2.86 μg). They studied the effect of ethanol in receptor compartment by applying fluorescent solution on skin using confocal laser scanning microscopy (CLSM) studies. There were no changes were observed for tested and controlled skin. Hence, they reported the presence of ethanol in receptor compartment does not affect on penetration behavior of fluorescent solution.
Jain et al. [42] developed methotrexate loaded ethosomes by thin film hydration technique using soya (1-3w/v %) and 3:1 chloroform and methanol. In their study, different concentrations of phospholipid and ethanol were applied for the development of ethosomes. They reported that increasing concentration of lipid increased particles size, whereas increasing concentration of ethanol decrease the particle size. It indicated that higher ethanol concentration decreased the thickness of bilayer vesicle membrane. They study the effect of temperature on the storage of ethosomes. They reported that increasing temperature increased particle size from the initial stage. The percent encapsulation efficiency was decreased. They suggested that 2-8°C conditions were more favor for their better stability. In vitro drug permeation studies showed more permeation from ethosomes (57. Dubey et al. [35] developed melatonin-loaded ethosomes for transdermal delivery. Ethosomes were developed by cold method, and liposomes were developed by film hydration technique. The in vitro permeation of ethosomes showed 59.2 ± 1.22 μg/h/cm −1 flux, whereas hydroethanolic solution and conventional liposomes showed 22.43 ± 0.24 μg/h/cm −1 and 10.9 ± 1.65 μg/h/cm −1 , respectively. They said that the combined effect of ethanol and phospholipid providing a mode for sustained delivery of melatonin. In their study, DSC experiment was utilized to predict the fluidity condition of liposomes and ethosomes vesicles. They reported that liposomes showed higher phase transition temperature (T m ) 16.6°C, whereas ethosomes showed −8.8°C. This statement indicates that ethanol showed the fluidizing effect on ethosomal vesicles.
Preparation methods for liposomes and ethosomes
Various methods are available to prepare vesicular colloidal dispersions. The main goals of development of vesicles are to increase the encapsulation efficiency and to avoid leakage of drug from them. In general, passive loading and active loading methods are available to formulate the vesicular dispersions [ Table 2 ].
Factors involved in active loading or remote loading [46, 47] The passive loading techniques are unable to produce 100% encapsulation efficiency of the active molecules into saturate by hydrogenation using phospholipase-D enzyme. Saturated phospholipids have a high phase transition temperature, and they have highly flowing property.
Natural lipids are more preferable compared to synthetic, but saturated state is more important parameter rather than source of lipids. Saturated lipids have high phase transition temperature promotes high encapsulation efficiency and less leakage during storage. For example, DOXIL is the first liposomal product of doxorubicin. Even AMBISOMES is amphotericin B loaded liposomal product approved by USFDA. Both products were made up of hydrogenated soya phosphatidylcholine (HSPC). Carbon chain lengths also imp parameters to affect the drug loading efficiency. Long chain length lipids have higher Vandeeer Waals attractive forces promote cohesive nature to decrease the drug leakage. The lipid and cholesterol ratio influences the drug loading efficiency of liposomes. Cholesterol has an impact on lipid bilayer membrane structural organization and influences the stability of liposomes by reducing the rotational freedom of the phospholipid hydrocarbon chain length helps stabilize the lipid bilayers. During development of liposomes, cholesterol controls the penetration and permeation of water into liposomes. In general, lipid and cholesterol concentrations 60:40 and 70:30 are more preferable.
The active or remote loading is an alternative method to passive loading methods to overcome drawbacks associated with passive loading techniques. Many liposomal marketed products made by active loading technique such as doxorubicin, daunorubicin, citicoline loaded liposomal products. Active pharmaceutical ingredients should pose some desirable properties such as amphiphilic or hydrophilic in nature, log D at pH 7 in the range of −2.5-2.0 and pKa ≤11.
The pH imbalance is the driving force for active loading of active molecules into liposomes. Various ammonium salts such as citrates, phosphates, and sulfate are useful loading molecules, e.g., doxorubicin, daunorubicin, citicoline, and ciprofloxacin. Metal ion gradients are another remote loading technique. MnSO 4 and MnCl 2 are used for topotecan. Active molecules once encapsulated into liposomes will be available in precipitating state or protonated in liposomes because of this reason 100% encapsulation can be desirable and can be overcome the toxicity troubles. Tangential flow filters are working (TFF) more efficiently to purify the external concentrations of concentration gradients salts without wastage of samples.
Evaluation parameters during development of liposomes and ethosomes
During the development of liposomes and ethosomes, various physical and chemical parameters are involved followed as Table 3 . Formulation of liposomes and ethosomes require similar components as listed in Table 4 . Each of the components in the vesicular system has its own significance for their presence in the formulation, which is described in detail.
Phospholipids
Although liposomes and ethosomes can be made using a variety of surface-active molecules, most commonly, used reagents are phospholipids. All hydrated phospholipids do not form bilayers, e.g. phosphatidylethanolamine form inverted hexagonal phases and lysophospholipids form spherical micelles. The common thing that exists for bilayer forming compounds is their amphiphilicity. Phospholipids are the lipid amphiphiles with two acyl chains with same or different numbers of carbon atoms in each chain varying from 10 to 24-C in number linked to hydrophilic phosphate head via the glycerol bridge. There are different types of phospholipids based on their origin either natural phospholipids or synthetic phospholipids. Natural phospholipids are mostly suitable for transdermal applications and list of natural phospholipids available are given in Table 5 . The synthetic phospholipids find their utility mainly when the parenteral route of administration is desired and different synthetic phospholipids available readily are mentioned in Table 6 . Parameters that are to be considered in selection of phospholipids that would govern the geometry and packing (p) are:
• Molecular volume of the hydrophobic part (v)
• The critical length of the hydrophobic hydrocarbon region (l c ) • The optimum surface per molecule at the hydrocarbonwater interface (α o ).
These are related to each other as per the below Equation:
P=v/(l c α o )
Role of liposomes and ethosomes on RA [50] [51] [52] [53] [54] [55] Arthritis is two types: One is acute and another one is chronic. Acute arthritis is characterized by rapid joint destruction and the duration of this stage from hours too few days, e.g., infectious arthritis and gout. Chronic arthritis is mediated by adaptive immune response by T-cells and macrophages. Duration of this stage is from days to weeks. Ex: RA, RA associated with ankylosing spondylitis. RA is an autoimmune disease that causes our body to attacks its own immune system. RA can also cause firm lumps under the skin known as rheumatoid nodules. When our immune system attacks the synovium, RA can occur. Synovium is the lining of the membrane that surrounds the joint which eventually invade and destroy the cartilage and bone within the joint. Arthritis of the joint is called synovitis. In this case, synovium becomes inflamed and swollen the synovial membrane. In synovitis, cell proliferation will take place with respect to T-cells, B-cells, macrophages, and plasma cells. In case, RA lymphocytes and macrophages continuously enter into the joint cavity and multiply the release of inflammatory mediators such as cytokines, leukotrienes, and prostaglandins. Within weeks, the synovium becomes thickened, the mass of synovial tissue spreads over the top of cartilage in a rheumatic joint called as "pannus." This is made of white blood cells (WBC). WBC consists macrophages, B-cells, T-cells, neutrophils, plasma cells T-helper cells. These all will produce rheumatic factor, prostaglandins, cytokines, and other mediators. The disease prevalence is more in female compared to males in humans.
In general, there is no proper medication for RA.
Non-steroidal anti-inflammatory drug (NSAIDS) has a lot of disadvantages such as low half-life, low bioavailability, frequent administration, and high doses to get desired concentration at the target site. On oral delivery, most of the NSAIDS such as etodolac, indomethacin, and ibuprofen are produce gastrointestinal bleeding, nausea, and vomiting. High doses lead to cause a toxic effect at the target site. They have first pass metabolism effect on the oral delivery. So, these drawbacks make increases the patient in-compliance. [50] [51] [52] [53] Currently, in the market, NSAIDS loaded various dosage forms such as gels, ointments, lotions, and creams are available for RA. However, they are failed to control the disease. These conventional dosage forms do not have proper permeation and penetration ability across the skin. At present, disease-modifying antirheumatic drugs (DMARDs) are more effective in reducing down disease progression. The basic mechanism of action of DMARDs in RA is not clear. Vesicular systems have been extensively played predominantly role as drug delivery systems in the treatment of RA. Till now, huge research was done on liposomes and ethosomes for RA by dermal, transdermal, and intravenous (IV) administrations. Liposomes and ethosomes are lipidbased vesicular systems. Basically, phospholipids can act as permeability enhancers. They have ability to increase cutaneous and percutaneous absorption of the drugs by transdermal route. [56] IV, [57] and intradermal [58] ) administration, RA drugs loaded stealth liposomes were increasing the systemic circulation and deliver the drugs at targeted sight. When applying topically, liposomes act as reservoir and it can localize the drug substance at the skin level and decrease the systemic absorption. For treating pain located in the joints, topical, or transdermal route is suitable. For example, corticosteroids are a good choice for treatment of RA, but these drugs show rapid clearance at the site of inflammation. Many reports state that liposomes are a selective choice to encapsulate corticosteroids into liposomal vesicles, and they had ability to delay the release and increased retention in treatment of RA. The advantages of topical delivery of corticosteroids loaded liposomes improve and prolong drug exposure in the inflamed area. According to Srinath et al. statement, <200 nm size of colloidal dispersions is more preferable for preferable for effective localization at the inflammation sites. [58] Du Plessis et al. [59] reported that liposomal mechanism of drug transport across the skin. They suggested that naturally phospholipids have permeability nature to cross the biological barriers. Phospholipids may mix with intercellular lipids and leads to form swelling effect which provides to form intracutaneous depot. On the other hand, Mezei and Gulasekharam, [31] Mezei, [32] and Barry [60] suggested that liposomes are not unable to penetrate into deeper multilayer of skin.
Even ethosomes also had an impact on anti-RA. [61] Touitou et al. [62] developed betamethasone dipropionate loaded ethosomes for transdermal delivery. They reported that accumulation of drug concentration was three times higher than diprolene cream in epidermis and dermis. Moreover, the anti-inflammatory activity was also higher from ethosomes. Lodzki et al. [63] and Touitou et al., developed cannabidiol loaded ethosomes for transdermal delivery. They reported that 49% of the loaded (845 g/cm 2 ) accumulated in within the viable skin tissue over 24-h period. In the in vivo studies also 110.7 ± 24.15 μg/cm 2 drug concentration was accumulated from ethosomes. ElSayed et al. [64] developed ketotifen loaded deformable liposomes and ethosomes for skin delivery. They reported that ethosomes showed higher drug concentration accumulated in the skin compared to deformable liposomes.
Chan et al. [65] developed nanosized ethosomes bearing ketoprofen for improved transdermal delivery. Ethosomal vesicles were prepared by the method reported elsewhere with some modifications. Size analysis of the optimized formulation showed that minimum vesicle size was observed to be 120.376 nm, whereas maximum was 410.2721 nm depending on the concentration of soya phosphatidylcholine and ethanol. Ethosomal formulation prepared with 3% SPC and 20% alcohol exhibited 175.8% entrapment efficiency, whereas alcohol concentration up to 40% entrapment efficiency was increased up to 78.77%. 1% soya phosphatidylcholine and 20% alcohol of formulations shows 81.475% of in vitro drug release. The flux was found to be 165.7719 μg/h/cm −1 , whereas lower flux 94.67103 μg/h/cm −1 was observed with hydroalcoholic drug solution. They reveal that ethosomal formulation showed better results as compared with a hydro alcoholic drug solution. CLSM confirmed that ethosomal system showing high fluorescent intensity of rhodamine 123 loaded formulations compared to hydroalcoholic drug solution of probe across skin. Paolino et al. [66] developed ethosomes for skin delivery of ammonium glycyrrhizinate in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity in human volunteers. Ethosomes were prepared by the cold method. Ethosomes elicited an increase of the in vitro percutaneous permeation of both methyl nicotinate and ammonium glycyrrhizinate ethosomes. As compared with methyl nicotinate ethosomes, ammonium glycyrrhizinate ethosomes showed better vesicle size ranges were observed between 350 and 100 nm, and entrapment efficiency was found to be 78. 45 . Finally, they state that the differences between methyl nicotinate and ammonium glycyrrhizinate in the cumulative amount of drug permeated through human stratum corneum epidermis from the same type of formulations were probably due to the different physicochemical properties of the two molecules because methyl nicotinate erythema depends on two principal factors: Vehicle composition and duration of application. These findings were probably due to the presence of ethanol that can improve the skin accumulation of ammonium glycyrrhizinate. Some of the additional supporting data as mentioned in Table 7 for liposomes and ethosomes for transdermal delivery.
CONCLUSION
By transdermal delivery, stratum corneum restricts or obstacle to entry for active molecule. Three different generations of transdermal delivery systems were developed increase transdermal flux and localization viable skin multilayers. However, they have poor distribution profiles by the transdermal route. The above review indicates that vesicular systems are an alternative source to improve transdermal drug delivery system profile. In the vesicular dispersions from (liposomes) Mezei to Elka Touitou (ethosomes), huge research was done. However, they'll be no clarity on the vesicular drug release mechanisms for transdermal delivery. Phospholipid is a weak emulsifier and natural permeating agent. In association with cholesterol, the permeability was restricted. Liposomal vesicle permeation rate was inversely proportional to the concentration of cholesterol. The lower concentration of cholesterol makes liposomes more permeability, whereas higher concentration cause more rigid in nature causes to decrease permeation through the skin. When compared to liposomes, ethosomes better for increase flux concentration of drugs across the skin. Particularly in ethosomes, ethanol itself acts as co-solvency for water and PC: Phosphatidylcholine, HSPC: Hydrogenated soya phosphatidylcholine permeation enhancer. During drug release process, there might be the synergistic effect of lipid and alcohol promotes ethosomes are more advanced than liposomes. However, the exact drug release mechanism was not clear. Still, it required some extent of research work on liposomes and ethosomes for transdermal delivery. Compared to parenteral route, there was no liposomal or ethosomal transdermal products in the market. The above-mentioned literature stated that vesicle able to localize and permeate transdermal concentrations of active substances across/into the skin. Liposomes compared to transdermal delivery, parenteral (IV) route of stealth liposomes ahead in the market. Because Doxil, ambisomes were entering the market. RA is a chronic disease; traditional RA treatment has huge disadvantages which we had mentioned above. The applicability of liposomes and ethosomes in RA increase the confidence to control the disease status by skin delivery.
